Literature DB >> 627320

Fasting and postprandial serum bile acid concentrations in normal persons using an improved GLC method.

C R Pennington, P E Ross, I A Bouchier.   

Abstract

An improved GLC method was employed to study individual serum bile acids in 14 control subjects after a 12-hour fast followed by a standard fatty meal. Peripheral venous blood samples were obtained at 15-min intervals for up to 2 h in 7 subjects, and 4 h in 2 subjects. The fasting total bile acids, and cholic:chenodeozycholic acid ratio fell within a narrow range. The total bile acids and chenodeoxycholic acid increased significantly within 30 min of the meal, to reach peak values within 75-120 min. The extent of the increase was variable, and the range of values increased progressively after the meal.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 627320     DOI: 10.1159/000198094

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  5 in total

Review 1.  Serum bile acids in hepatobiliary disease.

Authors:  I A Bouchier; C R Pennington
Journal:  Gut       Date:  1978-06       Impact factor: 23.059

2.  Systemic gut microbial modulation of bile acid metabolism in host tissue compartments.

Authors:  Jonathan R Swann; Elizabeth J Want; Florian M Geier; Konstantina Spagou; Ian D Wilson; James E Sidaway; Jeremy K Nicholson; Elaine Holmes
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-13       Impact factor: 11.205

3.  Influence of the gallbladder on serum bile acids.

Authors:  C R Pennington; P E Ross; I A Bouchier
Journal:  J Clin Pathol       Date:  1982-07       Impact factor: 3.411

4.  Enterohepatic circulation rates of cholic acid and chenodeoxycholic acid in man.

Authors:  K A Einarsson; S M Gundy; W G Hardison
Journal:  Gut       Date:  1979-12       Impact factor: 23.059

5.  Fluctuations of serum bile acid concentrations during the menstrual cycle.

Authors:  C R Pennington; P E Ross; J Murison; I A Bouchier
Journal:  J Clin Pathol       Date:  1981-02       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.